Rhinoconjunctivitis is a type of medical condition which is a combination of rhinitis and conjunctivitis.
This report contains market size and forecasts of Rhinoconjunctivitis in Global, including the following market information:
Global Rhinoconjunctivitis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rhinoconjunctivitis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Decongestants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rhinoconjunctivitis include Johnson & Johnson, GlaxoSmithKline, Merck & Co., Sanofi, Adiga Life Sciences Inc, Lofarma S.p.A, Biotech Tools, ALK-Abelló and Stallergenes Greer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rhinoconjunctivitis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rhinoconjunctivitis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rhinoconjunctivitis Market Segment Percentages, by Type, 2021 (%)
Decongestants
Mast-Cell Stabilizers
Antihistamines
Others
Global Rhinoconjunctivitis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rhinoconjunctivitis Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Research Center
Others
Global Rhinoconjunctivitis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rhinoconjunctivitis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rhinoconjunctivitis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rhinoconjunctivitis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
GlaxoSmithKline
Merck & Co.
Sanofi
Adiga Life Sciences Inc
Lofarma S.p.A
Biotech Tools
ALK-Abelló
Stallergenes Greer
HAL Allergy